Author:
Malek Vajir,Sharma Nisha,Gaikwad Anil Bhanudas
Funder
Science & Engineering Research Board – Department of Science & Technology (SERB-DST), Govt. of India
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Reference32 articles.
1. Neprilysin inhibitors: a new hope to halt the diabetic cardiovascular and renal complications?;Malek;Biomed Pharmacother,2017
2. Angiotensin–neprilysin inhibition in acute decompensated heart failure;Velazquez;N Engl J Med,2018
3. LCZ696, an angiotensin receptor–neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin‐induced diabetic mice;Suematsu;Eur J Heart Fail,2016
4. LCZ696 (sacubitril/valsartan), an angiotensin-receptor neprilysin inhibitor, attenuates cardiac hypertrophy, fibrosis and vasculopathy in a rat model of chronic kidney disease;Suematsu;J Card Fail,2018
5. LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy;Xia;J Mol Cell Cardiol,2017
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献